Business
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced upcoming presentations, including
About this update from Cytokinetics, Incorporated
[{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced upcoming presentations, including three Late Breaking Science presentations related to MAPLE-HCM (Metoprolol vs Aficamten in Patients with LVOT Obstruction on Exercise Capacity in HCM), at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions on November 7, 2025, and at the American Heart Association Scientific Sessions 2025 taking place November 7-10, 2025, both in New Orleans, LA. Hypertrophic Cardiomyopathy Medical Society Scientific Sessions Late Breaking Science Presentation Title: Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic CardiomyopathyPresenter: Michael E. Nassif, M.D., University of Missouri Kansas City Healthcare Institute for Innovations in Quality and Saint Luke’s Mid America Heart InstituteDate: November 7, 2025Session Title: Featured Science: Hypertrophic Cardiomyopathy Medical SocietySession Time: 6:00 PM – 6:35 PM CTPresentation Time: 6:16 PM – 6:22 PM CTLocation: R01 Oral Presentation Title: Long-term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM Presenter: Shepard D. Weiner, M.D., Columbia University Irving Medical CenterDate: November 7, 2025Session Title: Hypertrophic Cardiomyopathy Medical Society Oral AbstractsSession Time: 2:40 PM – 3:30 PM CTPresentation Time: 2:50 PM – 2:58 PM CTLocation: R02-R03 Poster Presentation Title: Outcomes Following Septal Myectomy in Young Patients with Obstructive Hypertrophic CardiomyopathyPresenter: Daniel Kamna, D.O., Oregon Health & Science UniversityDate: November 7, 2025Session Title: Hypertrophic Cardiomyopathy Medical Society PostersSession Time: 6:30 PM – 7:30 PM CTLocation: R04-R05 Posters American Heart Association Scientific Sessions 2025 Late Breaking Science Presentations Title: Clinical Responses to Aficamten Monotherapy Compared with Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy Outcomes and Disease Burden: MAPLE-HCM Responder AnalysisPresenter: Andrew Wang, M.D., Duke University Medical CenterDate: November 8, 2025Session Title: From Madrid to Mardi Gras: Heart Failure Trials on ParadeSession Time: 1:30 PM – 2:45 PM CTPresentation Time: 1:59 PM – 2:07 PM CTLocation: 211-213 Tit...